CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Practice and Policy

ONCOLOGY. Vol. 20 No. 10
Pages: 1  2  
Previous
The Kolb/Wallace/Hill et al Article Reviewed 

Disparities in Cancer Care Among Racial and Ethnic Minorities: Review 2

By

OTIS W. BRAWLEY, MD
Professor of Hematology, Oncology, Medicine and Epidemiology


MITCHELL BERGER, MD, MMM, CPE
Assistant Professor of Hematology and Oncology
Emory University
Atlanta, Georgia

| September 1, 2006

Financial Disclosure: The authors have no significant financial interest or other relationship with the manufacturers of any products or providers of any service mentioned in this article.

Some have called for increased accrual of minorities to clinical trials and suggested that this might help find treatments for diseases frequently seen in minorities. Reviews have demonstrated that, with few exceptions, equal treatment yields equal outcome among equal patients.[10] Race or ethnicity is not a factor in outcome, although pertinent molecular markers with differing racial/ethnic prevalences can be. Shavers and Brown have published a wonderful review demonstrating that treatment is not equal among the races.[3] Indeed, they cite evidence for significantly disparate treatment patterns in a number of diseases.

The authors correctly point out that cultural differences in the acceptance of therapy and a misunderstanding of cancer biology and principles of medical treatment are common reasons that optimal therapy is refused. We believe that health-care providers do not need to be of the same race as the patient, but do need to be sensitive to the needs, fears, and concerns of the patient (and open to dealing with those needs, fears, and concerns).

(MORE: Disparities in Cancer Care Among Racial and Ethnic Minorities)

Another factor that must be considered beyond the availability of good health care is the lack of convenience of therapy. Even when therapy is available, it may be refused or underutilized if it is inconvenient. We are personally aware of women with limited-stage breast cancer walking out on therapy at an indigent care facility, because they found that obtaining care was unpleasant. They had long waits for surgery and frequent postponements of scheduled procedures.

Conclusions

Several years ago, the federal government initiated a major effort to define the reasons why people are medically underserved. Many of us who worked on that project quickly realized that "the underserved are underserved because they are underserved, and the solution is to get them service." A major effort in minority health and health disparities research must be to determine how we can provide adequate high-quality care to populations that so often have not received it, regardless of race/ethnicity or socioeconomic status.

—Otis W. Brawley, MD
—Mitchell Berger, MD, MMM, CPE

Pages: 1  2  
Previous
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

This commentary refers to the following article

Disparities in Cancer Care Among Racial and Ethnic Minorities



BETHANY KOLB, MBA, MS IV; ANNE MARIE WALLACE, MD; DEIDRE HILL, PhD; MELANIE ROYCE, MD, PhD


1. Kolb B, Wallace AM, Hill D, et al: Disparities in cancer care among racial and ethnic minorities. Oncology (Williston Park) 20:1256-1261, 2006.

2. Brawley OW: Introduction: Cancer and health disparities. Cancer Metastasis Rev 22:7-9, 2003.

3. Shavers VL, Brown ML: Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 94:334-357, 2002.

4. Edwards BK, Brown ML, Wingo PA, et al: Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97:1407-1427, 2005.

5. Kramer BS, Brawley OW: Cancer screening. Hematol Oncol Clin North Am 14:831-848, 2000.

6. Brawley OW: Some perspective on black-white cancer statistics. CA Cancer J Clin 52:322-325, 2002.

7. Calle EE, Thun MJ: Obesity and cancer. Oncogene 23:6365-6378, 2004.

8. Amling CL: The association between obesity and the progression of prostate and renal cell carcinoma. Urol Oncol 22:478-484, 2004.

9. Gordon NH: Association of education and income with estrogen receptor status in primary breast cancer. Am J Epidemiol 142:796-803, 1995.

10. Bach PB, Schrag D, Brawley OW, et al: Survival of blacks and whites after a cancer diagnosis. JAMA 287:2106-2113, 2002.


 
RELATED CONTENT

How the Sequester Cuts Are Harming Oncology
ONCOLOGY,  May 15, 2013
Are CML Drugs Priced Out of Reach?
May 2, 2013
US Cancer Organizations Say Medicare Cuts Will Negatively Impact Cancer Patients
April 29, 2013
Oncologists Hope Congress Will Exempt Cancer Drugs From Sequester Cuts
April 27, 2013
Groups Issue New Social Media Guidelines for Physicians
April 26, 2013
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • A 49-Year-Old Woman Develops Thickened and Bound-Down Skin
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • US Task Force Recommends Breast Cancer Medications for High-Risk Women
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Preventing Exposure to Hazardous Drugs
  • Conflicts of Interest in Medicine: What About Ties to Payers?
  • Planning Treatment for Women With Recurrent Epithelial Ovarian Cancer
  • Rising PSA Level in a 46-Year-Old Man
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
Click here to subscribe to our newsletter


CancerNetwork on Facebook
 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Health Care
Evidence on Health Care
Guidelines on Health Care
Patient Education on Health Care
Clinical Trials on Health Care
Practical Articles on Health Care
Research and Reviews on Health Care
All "Health Care" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy